Affinity Asset Advisors, LLC Closed Holding Positions

Affinity Asset Advisors, LLC

  • $579 Million
  • Q3 2024
Stock Closed Quarter Shares Sold Price Range Trade History
Bctg Acquisition Corp
Q3 2021 Filed on Nov 12, 2021
100,000
N/A
EPIX
Essa Pharma Inc.

Healthcare
Q3 2021 Filed on Nov 12, 2021
70,000
$7.76 - $29.37 $543K - $2.06M
Chardan Healthcr Acqstn 2 CO
Q3 2021 Filed on Nov 12, 2021
75,000
N/A
MGNX
Macrogenics Inc

Healthcare
Q3 2021 Filed on Nov 12, 2021
80,000
$19.74 - $28.7 $1.58M - $2.3M
IONS
Ionis Pharmaceuticals Inc

Healthcare
Q3 2021 Filed on Nov 12, 2021
75,000
$33.54 - $40.55 $2.52M - $3.04M
CVRX
Cv Rx, Inc.

Healthcare
Q3 2021 Filed on Nov 12, 2021
7,500
$14.65 - $26.07 $110K - $196K
VRTX
Vertex Pharmaceuticals Inc

Healthcare
Q2 2021 Filed on Aug 13, 2021
50,000
$187.49 - $221.1 $9.37M - $11.1M
CCCC
C4 Therapeutics, Inc.

Healthcare
Q2 2021 Filed on Aug 13, 2021
20,000
$30.39 - $42.18 $608K - $844K
SNDX
Syndax Pharmaceuticals Inc

Healthcare
Q2 2021 Filed on Aug 13, 2021
190,500
$13.42 - $25.18 $2.56M - $4.8M
BYSI
Beyond Spring Inc.

Healthcare
Q2 2021 Filed on Aug 13, 2021
50,000
$9.37 - $12.12 $468K - $606K
RUBY
Rubius Therapeutics, Inc.

Healthcare
Q2 2021 Filed on Aug 13, 2021
70,000
$22.26 - $28.43 $1.56M - $1.99M
BLUE
Bluebird Bio, Inc.

Healthcare
Q2 2021 Filed on Aug 13, 2021
50,000
$18.04 - $22.09 $902K - $1.1M
Vincerx Pharma Inc
Q2 2021 Filed on Aug 13, 2021
218,000
N/A
ZYNE
Zynerba Pharmaceuticals, Inc.

Healthcare
Q2 2021 Filed on Aug 13, 2021
13,285
$3.83 - $5.98 $50.9K - $79.4K
XFOR
X4 Pharmaceuticals, Inc

Healthcare
Q2 2021 Filed on Aug 13, 2021
75,000
$6.49 - $9.56 $487K - $717K
WINT
Windtree Therapeutics Inc

Healthcare
Q2 2021 Filed on Aug 13, 2021
42,847
$1.68 - $2.79 $72K - $120K
STRO
Sutro Biopharma, Inc.

Healthcare
Q2 2021 Filed on Aug 13, 2021
80,000
$18.03 - $23.82 $1.44M - $1.91M
Medicus Sciences Acquisition
Q2 2021 Filed on Aug 13, 2021
300,000
N/A
Highcape Cap Acquisition Cor
Q2 2021 Filed on Aug 13, 2021
150,000
N/A
Arya Sciences Acquisition CO
Q2 2021 Filed on Aug 13, 2021
689,000
N/A
EPZM
Epizyme, Inc.

Healthcare
Q2 2021 Filed on Aug 13, 2021
50,000
$6.81 - $9.71 $341K - $486K
ATNX
Athenex, Inc.

Healthcare
Q1 2021 Filed on May 14, 2021
200,000
$4.08 - $14.75 $816K - $2.95M
VXRT
Vaxart, Inc.

Healthcare
Q1 2021 Filed on May 14, 2021
25,000
$5.64 - $23.33 $141K - $583K
Eidos Therapeutics Inc
Q1 2021 Filed on May 14, 2021
225,000
N/A
Chardan Healthcare Acquisition 2 Corp
Q1 2021 Filed on May 14, 2021
75,000
N/A
Dicerna Pharmaceuticals Inc
Q1 2021 Filed on May 14, 2021
40,000
N/A
CRSP
Crispr Therapeutics Ag

Healthcare
Q1 2021 Filed on May 14, 2021
3,500
$110.72 - $210.04 $388K - $735K
Pandion Therapeutics Inc
Q1 2021 Filed on May 14, 2021
80,000
N/A
OM
Outset Medical, Inc.

Healthcare
Q1 2021 Filed on May 14, 2021
10,000
$46.94 - $58.66 $469K - $587K
Vesper Healthcare Acquisition Corp
Q1 2021 Filed on May 14, 2021
100,000
N/A
MGTX
Meira G Tx Holdings PLC

Healthcare
Q1 2021 Filed on May 14, 2021
100,000
$13.84 - $17.8 $1.38M - $1.78M
LYRA
Lyra Therapeutics, Inc.

Healthcare
Q1 2021 Filed on May 14, 2021
50,000
$10.38 - $15.61 $519K - $781K
Longview Acquisition Corp
Q1 2021 Filed on May 14, 2021
75,000
N/A
LPTX
Leap Therapeutics, Inc.

Healthcare
Q1 2021 Filed on May 14, 2021
904,600
$1.82 - $3.01 $1.65M - $2.72M
SLDB
Solid Biosciences Inc.

Healthcare
Q1 2021 Filed on May 14, 2021
250,000
$5.37 - $10.72 $1.34M - $2.68M
SIOX
Sio Gene Therapies Inc.

Healthcare
Q1 2021 Filed on May 14, 2021
250,000
$2.34 - $3.44 $585K - $860K
Track This Portfolio

Track Affinity Asset Advisors, LLC Portfolio

Follow Affinity Asset Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Affinity Asset Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Affinity Asset Advisors, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email